Physician profile
Marc A Ward
NPI 1861715476
$21,944.90
in general payments reported to CMS, 2019-2025
15 companies · $626 in 2025
The $626 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $1,061 · 2021: $517 · 2022: $9,978 · 2023: $8,697 · 2024: $492 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,000 · Food and Beverage: $1,433 · Travel and Lodging: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,000.00 |
| Food and Beverage | $1,432.82 |
| Travel and Lodging | $1,382.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,179.69 | 2021-2023 | Da Vinci Sp |
| Boston Scientific Corporation | $10,124.05 | 2019-2025 | Overstitch Nxt Endoscopic Suturing System |
| Enterra Medical, INC. | $867.48 | 2024-2025 | |
| Ethicon US, LLC | $277.78 | 2019-2025 | Echelon; Endopath, Enseal, Vistaseal |
| Medtronic, INC. | $142.06 | 2021-2025 | Signia, Ligasure |
| Covidien LP | $63.78 | 2019-2020 | |
| New View Surgical, INC. | $52.75 | 2023 | Visionport System |
| Davol INC. | $50.15 | 2022 | |
| Tela Bio, INC. | $47.22 | 2024 | Ovitex 2s |
| Apollo Endosurgery US INC | $46.74 | 2021-2022 | |
| Integra Lifesciences Corporation | $32.52 | 2022-2023 | Durasorb Monofilament Mesh |
| Allergan, INC. | $20.24 | 2019 | |
| Kci USA, INC. | $16.13 | 2020 | |
| Pfizer INC. | $15.12 | 2021 | |
| Bolder Surgical LLC | $9.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.